Michael Makris on Non-Malignant Haematology
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn:
”What do you call the specialty of “non-malignant haematology”?
Everybody agrees that non-malignant haematology is not a good term.
Our US colleagues, backed by ASH, have chosen to go with “Classical Hematology”.
I have discussed this with colleagues in the UK and Europe, and have not met a single haematologist who likes the term Classical Haematology.
We now have a new name proposed: Medical Haematology.
A paper in the British Journal of Haematology discusses this in detail, including why this term is preferred to Classical Haematology, and also how this is integrated with hospital medicine and the future of the specialty.
My personal view is that our specialty should be called Medical not Classical Haematology.”
Read the full article here.
Article: Medical haematology: Repositioning haematology at the centre of medicine
Authors: Cheng Hock Toh, Imelda Bates, Sue Pavord
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases
-
Jan 27, 2026, 08:11Matthew Flick Links Urokinase Plasminogen Activator Deficiency to Obesity
-
Jan 26, 2026, 09:15Pablo Corral on Lipid-Lowering Therapy and Cognition: Evidence vs Myth